• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

17
1
1
1

COUNTRY

1

CATEGORIES

  • 10
  • 8
  • 7
  • 7
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

11
11
12
33

PUBLISHED

3
6
8
33

PRODUCT TYPE

24
7
1
1

Search "Immuno-Biological Laboratories Co., Ltd" returned 33 results.

PRODUCT TITLE
Immuno-Biological Laboratories Co., Ltd. - Company Capsule Immuno-Biological Laboratories Co., Ltd. - Company Capsule - Product Thumbnail Image

Immuno-Biological Laboratories Co., Ltd. - Company Capsule

Synopsis Consumer Packaged Goods's "Immuno-Biological Laboratories Co., Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company...

September 2012
FROM

Immuno-Biological Laboratories Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Immuno-Biological Laboratories Company Limited

A textual analysis of the financial results for Immuno-Biological Laboratories Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

April 2015
FROM
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 69...

April 2010
FROM

Hepatitis B - Pipeline Review, H1 2013

Hepatitis B – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis B - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment The National Cancer Institute estimates that about ten million Americans...

May 2013
FROM

Life Science & Chemical Instrumentation Market (2011 – 2016) (Spectroscopy, Chromatography, Dna Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Global Trends, End User & Competitive Analysis

Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)...

February 2012
FROM
Multiple Myeloma Therapeutics - Global Strategic Business Report Multiple Myeloma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

October 2011
FROM

Pharmesis International Ltd

A textual analysis of the financial results for Pharmesis International Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

March 2015
FROM

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued...

November 2013
FROM

Onco Therapy Science, Inc

A textual analysis of the financial results for Onco Therapy Science, Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

April 2015
FROM
Canadian Biotechnology Industry Guide 2013 Canadian Biotechnology Industry Guide 2013 - Product Thumbnail Image

Canadian Biotechnology Industry Guide 2013

Canada's most comprehensive and widely used national information resource for the Biotechnology industry This annual, comprehensive vehicle is used by biotech company executives, industry stakeholders,...

January 2013
FROM
Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) - Product Thumbnail Image

Cancer Diagnostics Partnering Terms and Agreements (3rd Edition)

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. ...

December 2014
FROM
Hepatitis - Pipeline Review, H1 2013 Hepatitis - Pipeline Review, H1 2013 - Product Thumbnail Image

Hepatitis - Pipeline Review, H1 2013

Hepatitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

March 2013
FROM
Autoimmune Disorders - Pipeline Review, H2 2012 Autoimmune Disorders - Pipeline Review, H2 2012 - Product Thumbnail Image

Autoimmune Disorders - Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline....

August 2012
FROM
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities Delivering New Biopharmaceutical Therapies: Challenges & Opportunities - Product Thumbnail Image

Delivering New Biopharmaceutical Therapies: Challenges & Opportunities

“Over the last decade, biotech antibodies have provided some of the biggest breakthroughs in medicine The list includes Avastin, Herceptin, Rituxan and Erbitux for cancer and Enbrel, Humira, and Remicade...

March 2009

KM R&C Co Ltd

A textual analysis of the financial results for KM R&C Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

May 2015
FROM

Molecular Diagnostics Reports Bundle

The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately: - Molecular Diagnostics in Cancer Testing - Molecular...

November 2013
FROM
Human Vaccines - Global Strategic Business Report Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines The report...

March 2012
FROM

Muller and Phipps (Ceylon) Plc

A textual analysis of the financial results for Muller and Phipps (Ceylon) Plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

April 2015
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG